logo
logo
Sign in

E-Prescribing Is Fastest Growing Segment Fueling The Growth Of Opioid Use Disorder Market

avatar
Leena Shedmake
E-Prescribing Is Fastest Growing Segment Fueling The Growth Of Opioid Use Disorder Market

The global Opioid Use Disorder Market is estimated to be valued at US$ 3236.55 Mn or Bn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.



Market Overview:


Opioid use disorder treatment products includes medications which are used to treat opioid addiction and withdrawal symptoms. These medicines help by satisfying opioid cravings and withdrawing physical dependence.



Market key trends:


The increasing adoption of e-prescription for opioid use disorder treatment is expected to drive the market growth over the forecast period. E-prescribing allows physicians to transmit prescription orders to a pharmacy electronically instead of using handwritten or faxed prescriptions. This eliminates errors caused due to handwritten text and also improves accessibility for patients to fill their prescriptions according to their convenience by sending the orders directly to their preferred pharmacy.


Segment Analysis


The opioid use disorder market is segmented by type, application, and distribution channel. By type, the market is segmented into buprenorphine, methadone, naltrexone, and others. The buprenorphine segment dominates the opioid use disorder market as buprenorphine acts as an opioid agonist-antagonist which results in minimal withdrawal effects without the risk of overdose and is thus more preferred treatment over other treatment types.


By application, the market is segmented into pain management, addiction treatment, and others. The addiction treatment segment holds the largest share in the opioid use disorder market owing to the increasing prevalence of opioid addiction globally.


By distribution channel, the market is segmented into online pharmacies, retail pharmacies & drug stores, hospital pharmacies, online stores. Retail pharmacies & drug stores hold the major share as it is the most accessible channel of distribution to patients.



Key Takeaways


The Global Opioid Use Disorder Market Size is expected to witness high growth, exhibiting a CAGR of 8.7% over the forecast period, due to the increasing prevalence of opioid addiction and abuse globally.


Regional analysis:

North America holds the largest share in the opioid use disorder market owing to the high prevalence of opioid addiction in countries like the U.S. and Canada. Europe is anticipated to be the fastest-growing region in the market during the forecast period due to growing awareness and availability of treatment options in the region.


Key players:

Key players operating in the opioid use disorder market are Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, and Camurus. Indivior PLC is among the leading players owing to its blockbuster drug Suboxone used for the treatment of opioid dependence.

 

Explorer more information on this topic, Please visit-

https://www.marketwebjournal.com/opioid-use-disorder-market-growth-and-trnds-analysis-share-size-demand-forecast/

collect
0
avatar
Leena Shedmake
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more